Clinical impact of prevention and control of nosocomial infection on MDRO infection control in ICU

Jiaoe Cao; Yan Meng; Sha Zhou

doi:10.11910/j.issn.2791-2043.2024.1.06

Your Location：

Home >

Browse articles >

Clinical impact of prevention and control of nosocomial infection on MDRO infection control in ICU

MONOGRAPHIC STUDY | Updated：2024-05-30

- Clinical impact of prevention and control of nosocomial infection on MDRO infection control in ICU
- Sterile Supply Vol. 3, Issue 1, (2024)
- Affiliations：
  
  Yueyang People’s Hospital, Affiliated Hospital of Hunan Normal University, Yueyang, Hunan, 414000, China
- Author bio：
- Funds：
- DOI：10.11910/j.issn.2791-2043.2024.1.06
  CLC：
- Published：15 May 2024，
Scan for full text
Cao Jiaoe,Meng Yan,Zhou Sha.Clinical impact of prevention and control of nosocomial infection on MDRO infection control in ICU[J].Sterile Supply,2024,03(01):41-45.
DOI：

Cao Jiaoe,Meng Yan,Zhou Sha.Clinical impact of prevention and control of nosocomial infection on MDRO infection control in ICU[J].Sterile Supply,2024,03(01):41-45. DOI： 10.11910/j.issn.2791-2043.2024.1.06.

摘要

Abstract

Objective

The present study explores the clinical value of prevention and control of nosocomial infections for improving infection control in multidrug-resistant organisms (MDROs) in ICU.

Methods

A total of 200 patients in the intensive care unit (ICU) of Yueyang People's Hospital between January 2023 and March 2024 were randomly selected as study samples. Patients were divided into two groups according to the implementation time of prevention and control of nosocomial infection

i.e.

before prevention and control of nosocomial infection (control group) (

=100 cases) and after prevention and control of nosocomial infection (treatment group) (

=100 cases). Comparisons were made between before and after prevention and control of nosocomial infection for MDRO infection incidence

quality score for prevention and control of nosocomial infection

and sanitization pass rate.

Results

A parallel comparison between groups of MDRO infection incidence shows 1.00% in the treatment group and 8.00% in the control group (

0.05). Comparing air

object surfaces

and nurses' hands in parallel in groups and between groups

the sanitization pass rates were higher

in the control group than those of the treatment group (

0.05). In a parallel between-group comparison

the quality scores of hand hygiene

occupational exposure

disinfection and isolation

medical waste disposal

and sterile technique for prevention and control of nosocomial infection are higher in the control group than the treatment group (

0.05).

Conclusion

Prevention and control of nosocomial infections effectively improve the effect of MDRO infection control in the ICU.

关键词

Keywords

ICUMDROPrevention and control of nosocomial infection

references

Q. Li, R. Yang, X.S. Zhou et al., “Risk factors analysis and nomogram model evaluation of multi-drug resistant organism infection in intensive care unit patients,” China Medicine, vol. 19, pp. 426-430, 2024..

S. Tang, “Analysison the distribution and drug resistance of multidrug resistant bacteria in different departments,” Journal of Shaoyang University (Natural Science Edition), vol. 20, pp. 102-109, 2023.

X.Q. Liang, J.H. Liang, X.L. Mai, et al, “Application of visual identification management in infection control of multi-drug resistant bacteria in hospital ICU,” Modern Nurse, vol. 29, pp. 156-159, 2022.

D.M. Ni, S.N. Ge, L. Wang, et al, “Application and effect analysis of information management in prevention and control of multi-drug resistant bacteria,” Chinese Journal of Hospital Administration, vol. 35, pp. 74-77, 2019.

L.Q. Gu. “Analysis of the clinical impact of nosocomial infection prevention and control on infection control of multidrug-resistant bacteria in ICU” [J]. Home Medicine,2021,12(1):93.

J. Jerry, E. O’Regan, L. O’Sullivan et al., “Do established infection prevention and control measures prevent spread of SARS-CoV-2 to the hospital environment beyond the patient room?” The Journal of Hospital Infection, vol. 105, no. 4, pp. 589-592, 2020.

A. van Buijtene and D. Foster, “Does a hospital culture influence adherence to infection prevention and control and rates of healthcare associated infection? A literature review,” Journal of Infection Prevention, vol. 20, no. 1, pp. 5-17, 2019.

J.H. Lu, R.Y. Li, T. Zhang, et al, “Analysis of nosocomial infection and drug resistance of multidrug-resistant bacteria,” Clinical Journal of Diabetes World, vol. 17, p. 93, 2020.

J. Li, “Application analysis of continuous quality improvement in ICU infection control of multi-drug resistant bacteria,” China Health Standard Management, vol. 12, pp. 123-126, 2021.

C.Y. Shen, J. Wang, T. Lin et al., “Distribution and risk factors of multi-drug resistant bacteria infection after liver transplantation,” Journal of Hepatopancreatobiliary Surgery, vol. 32, pp. 355-360, 2020.

C.X. Luo, “Influence of quality control circle management on infection control of multi-drug resistant bacteria in ICU patients,” Nursing Practice and Research, vol. 16, pp. 36-38, 2019.

S. M. Havers, E. Kate Martin, A. Wilson et al., “A systematic review and meta-synthesis of policy intervention characteristics that influence the implementation of government-directed policy in the hospital setting: implications for infection prevention and control,” Journal of Infection Prevention, vol. 21, no. 3, pp. 84-96, 2020.

V. Brueton, L. Mooney and N. Wigglesworth, “Extending infection prevention and control nursing (IPCN) provision to weekends at one National Health Service hospital in the United Kingdom: a feasibility and acceptability study,” Journal of Infection Prevention, vol. 24, no. 4, pp. 178-181, Jul. 2023.

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰